Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients -2

NCT05433779 is registered in ClinicalTrials.gov with Neosense Technologies as lead sponsor.

NCT NCT05433779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05433779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal intensiVE Care Patients -2
Lead sponsor
Neosense Technologies
Phase
Not applicable
Overall status
Terminated
Start date
December 15, 2022
Completion date
June 16, 2023
Enrollment
8 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

catheter, lung diseases, newborn, infant, disease